Cargando…

Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso

OBJECTIVES: Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) are common sexually transmitted infections (STI). We assessed the cumulative risk of NG and CT in a cohort of HIV-1-infected high-risk women taking antiretrovirals over 4 years in Burkina Faso. METHODS: Between March 2007 and Febr...

Descripción completa

Detalles Bibliográficos
Autores principales: Low, Andrea J, Konate, Issouf, Nagot, Nicolas, Weiss, Helen A, Mabey, David, Segondy, Michel, Vickerman, Peter, Meda, Nicolas, van de Perre, Philippe, Mayaud, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932980/
https://www.ncbi.nlm.nih.gov/pubmed/24337732
http://dx.doi.org/10.1136/sextrans-2013-051233
_version_ 1782304854164635648
author Low, Andrea J
Konate, Issouf
Nagot, Nicolas
Weiss, Helen A
Mabey, David
Segondy, Michel
Vickerman, Peter
Meda, Nicolas
van de Perre, Philippe
Mayaud, Philippe
author_facet Low, Andrea J
Konate, Issouf
Nagot, Nicolas
Weiss, Helen A
Mabey, David
Segondy, Michel
Vickerman, Peter
Meda, Nicolas
van de Perre, Philippe
Mayaud, Philippe
author_sort Low, Andrea J
collection PubMed
description OBJECTIVES: Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) are common sexually transmitted infections (STI). We assessed the cumulative risk of NG and CT in a cohort of HIV-1-infected high-risk women taking antiretrovirals over 4 years in Burkina Faso. METHODS: Between March 2007 and February 2011, participants were followed every 3–6 months. At each visit, participants underwent a gynaecological examination with collection of cervical and vaginal swabs. Random-effects logistic regression models were used to analyse associations of NG and CT infection with behavioural and biological factors. RESULTS: 172 women had samples tested for NG and CT during the study period, in a total of 1135 visits. NG was detected in 6.4% of women (11/172, 95% CI 2.7 to 10.1) at a rate of 2.76 cases (95% CI 1.53 to 4.99) per 100 person-years. CT was detected in 1.7% (3/172, 95% CI 0 to 3.7) of women at a rate of 0.75 cases (95% CI 0.24 to 2.34) per 100 person-years. The majority of women were asymptomatic (9/14). In the multivariable model, the presence of NG or CT was associated with tobacco use (aOR=11.85, 95% CI 1.13 to 124.17), and concurrent genital HIV-1 RNA shedding (aOR=4.78, 95% CI 1.17 to 19.46). Higher levels of education (aOR=0.17, 95% CI 0.03 to 0.92), and age greater than 35 years (aOR=0.07, 95% CI 0.01 to 0.92) were associated with lower odds of infection. CONCLUSIONS: The risk of NG or CT infection remains low among high-risk women in Bobo-Dioulasso. This provides some evidence that antiretroviral use does not contribute to behavioural disinhibition. The asymptomatic nature of most infections underscores the need for regular screening and treatment of STIs in core groups.
format Online
Article
Text
id pubmed-3932980
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-39329802014-02-24 Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso Low, Andrea J Konate, Issouf Nagot, Nicolas Weiss, Helen A Mabey, David Segondy, Michel Vickerman, Peter Meda, Nicolas van de Perre, Philippe Mayaud, Philippe Sex Transm Infect Clinical OBJECTIVES: Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) are common sexually transmitted infections (STI). We assessed the cumulative risk of NG and CT in a cohort of HIV-1-infected high-risk women taking antiretrovirals over 4 years in Burkina Faso. METHODS: Between March 2007 and February 2011, participants were followed every 3–6 months. At each visit, participants underwent a gynaecological examination with collection of cervical and vaginal swabs. Random-effects logistic regression models were used to analyse associations of NG and CT infection with behavioural and biological factors. RESULTS: 172 women had samples tested for NG and CT during the study period, in a total of 1135 visits. NG was detected in 6.4% of women (11/172, 95% CI 2.7 to 10.1) at a rate of 2.76 cases (95% CI 1.53 to 4.99) per 100 person-years. CT was detected in 1.7% (3/172, 95% CI 0 to 3.7) of women at a rate of 0.75 cases (95% CI 0.24 to 2.34) per 100 person-years. The majority of women were asymptomatic (9/14). In the multivariable model, the presence of NG or CT was associated with tobacco use (aOR=11.85, 95% CI 1.13 to 124.17), and concurrent genital HIV-1 RNA shedding (aOR=4.78, 95% CI 1.17 to 19.46). Higher levels of education (aOR=0.17, 95% CI 0.03 to 0.92), and age greater than 35 years (aOR=0.07, 95% CI 0.01 to 0.92) were associated with lower odds of infection. CONCLUSIONS: The risk of NG or CT infection remains low among high-risk women in Bobo-Dioulasso. This provides some evidence that antiretroviral use does not contribute to behavioural disinhibition. The asymptomatic nature of most infections underscores the need for regular screening and treatment of STIs in core groups. BMJ Publishing Group 2014-03 2013-12-13 /pmc/articles/PMC3932980/ /pubmed/24337732 http://dx.doi.org/10.1136/sextrans-2013-051233 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/3.0/
spellingShingle Clinical
Low, Andrea J
Konate, Issouf
Nagot, Nicolas
Weiss, Helen A
Mabey, David
Segondy, Michel
Vickerman, Peter
Meda, Nicolas
van de Perre, Philippe
Mayaud, Philippe
Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso
title Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso
title_full Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso
title_fullStr Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso
title_full_unstemmed Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso
title_short Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso
title_sort neisseria gonorrhoeae and chlamydia trachomatis infection in hiv-1-infected women taking antiretroviral therapy: a prospective cohort study from burkina faso
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932980/
https://www.ncbi.nlm.nih.gov/pubmed/24337732
http://dx.doi.org/10.1136/sextrans-2013-051233
work_keys_str_mv AT lowandreaj neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso
AT konateissouf neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso
AT nagotnicolas neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso
AT weisshelena neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso
AT mabeydavid neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso
AT segondymichel neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso
AT vickermanpeter neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso
AT medanicolas neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso
AT vandeperrephilippe neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso
AT mayaudphilippe neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso
AT neisseriagonorrhoeaeandchlamydiatrachomatisinfectioninhiv1infectedwomentakingantiretroviraltherapyaprospectivecohortstudyfromburkinafaso